Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 9/20 | 0.36 |
| ▸ | NOS2 | P35228 | 5/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.35 |
| ▸ | NOS3 | P29474 | 3/20 | 0.34 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29854874 | 1.00 | CYP3A4 (0.57) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL1191679 | 0.94 | CYP3A4 (0.57) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL1683975 | 0.93 | CYP3A4 (0.71) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL6805641 | 0.88 | CYP3A4 (0.47) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL22080193 | 0.87 | CYP3A4 (0.44) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL20124020 | 0.85 | CYP3A4 (0.61) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL842651 | 0.84 | MAPK1 (0.46) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL31182115 | 0.84 | CYP3A4 (0.44) | CYP3A4TSHRCYP1A2MAPK1TDP1 | |
| SCHEMBL58461 | 0.84 | GABRA1 (0.50) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL125649 | 0.84 | CYP3A4 (0.44) | CYP3A4TSHRCYP1A2MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | ENEVATE CORP (US) | 2024-10-03 | — | — | US | claimed |
| CN-117999255-A | Method for producing at least one aromatic isocyanate | 巴斯夫欧洲公司 | 2024-05-07 | — | — | CN | claimed |
| WO-2023041781-A1 | A PROCESS FOR PREPARING AT LEAST ONE AROMATIC ISOCYANATE | BASF SE (DE) | 2023-03-23 | — | — | WO | claimed |
| US-11427684-B2 | Photopatterned planarization layers for flexible electronics | ARES Materials, Inc. (US) | 2022-08-30 | — | — | US | claimed |
| CN-114408895-A | Multifunctional high-porosity high-thermal-conductivity carbon aerogel based on polymer aerogel and preparation method thereof | 福州大学 | 2022-04-29 | — | — | CN | claimed |
| US-11091581-B2 | Coated polyester films | DUPONT TEIJIN FILMS U.S. LIMITED PARTNERSHIP (US) | 2021-08-17 | — | — | US | claimed |
| WO-2021158366-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | ENEVATE CORPORATION (US) | 2021-08-12 | — | — | WO | claimed |
| US-20210249689-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | ENEVATE CORPORATION | 2021-08-12 | — | — | US | claimed |
| US-20210147631-A1 | PHOTOPATTERNED PLANARIZATION LAYERS FOR FLEXIBLE ELECTRONICS | ARES Materials, Inc. | 2021-05-20 | — | — | US | claimed |
| US-20200316904-A1 | MULTILAYER STRUCTURE, PRODUCTION AND USE THEREOF | COVESTRO DEUTSCHLAND AG (DE) | 2020-10-08 | — | — | US | claimed |
| US-4820745-A | SOLVENT-FREE | HUELS TROISDORF AKTIENGESELLSCHAFT (DE) | 1989-04-11 | — | — | US | claimed |
| EP-0297252-A2 | Crosslinked polyetherurethane membranes useful in blood electrolyte sensors | Becton, Dickinson and Company (US) | 1989-01-04 | — | — | EP | claimed |
| US-4743629-A | Crosslinked polyetherurethane membranes useful in blood electrolyte sensors | BECTON, DICKINSON AND COMPANY (US) | 1988-05-10 | — | — | US | claimed |
| US-4287255-A | HAVING A RELEASE SURFACE AND AN ADHESIVE LAYER CONTAINING A PHOTOPOLYMERIZABLE COMPOUND AND A CURED POLYMER STRIP | AVERY INTERNATIONAL CORPORATION (US) | 1981-09-01 | — | — | US | claimed |
| US-4118442-A | Anaerobic pressure sensitive adhesive composition | AVERY PRODUCTS CORPORATION (US) | 1978-10-03 | — | — | US | claimed |
| US-4092374-A | Anaerobic pressure sensitive adhesive composition | AVERY PRODUCTS CORPORATION (US) | 1978-05-30 | — | — | US | claimed |
| US-4092376-A | Anaerobic pressure sensitive adhesive composition | AVERY PRODUCTS CORPORATION (US) | 1978-05-30 | — | — | US | claimed |
| US-4039705-A | SHEETS AND TAPES, TWO DIFFERENTIAL RELEASE SURFACES | AVERY INTERNATIONAL CORPORATION (US) | 1977-08-02 | — | — | US | claimed |
| US-3996308-A | Anaerobic pressure sensitive adhesive composition | AVERY PRODUCTS CORPORATION (US) | 1976-12-07 | — | — | US | claimed |
| US-3993815-A | Anaerobic pressure sensitive adhesive stocks | AVERY PRODUCTS CORPORATION (US) | 1976-11-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | SIRT3, SLC6A12, HCN2 | CYP3A4 4039/4885TSHR 4711/4885CYP1A2 4588/4885 |
| US-20210249689-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | SIRT3, SLC6A12, HCN2 | CYP3A4 4039/4885TSHR 4711/4885CYP1A2 4588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.